Yuichiro Semba

649 citations
35 papers · 305 indexed · h-index 12
Topics
Acute Myeloid Leukemia Research (8 papers)CRISPR and Genetic Engineering (7 papers)Chronic Myeloid Leukemia Treatments (5 papers)

In The Last Decade

Yuichiro Semba

27 papers receiving 304 citations

Peers

Yuichiro Semba
Comparison fields: 5 of 66
  • Molecular Biology 203
  • Hematology 60
  • Public Health, Environmental and Occupational Health 41
  • Genetics 39
  • Genetics 33
Replace Kyomi J. Igarashi with:
Kyomi J. Igarashi United States
Flávia S. Donaires Brazil
Grace Hancock United States
Stella J. Nylund Finland
Marina Manvelyan Germany
Yeguang Hu United States
Roberto Fiorini Italy
Gerald L. Arthur United States
Caila Ryan United States
Vladimira Sulcova United States
Yuichiro Semba relative to Kyomi J. Igarashi United States Kyomi J. Igarashi's profile →
Citations per field
00.5×12×
Kyomi J. Igarashi · 1×
Citations per year

Countries citing papers authored by Yuichiro Semba

Since Specialization
Citations

This map shows the geographic impact of Yuichiro Semba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuichiro Semba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuichiro Semba more than expected).

Fields of papers citing papers by Yuichiro Semba

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuichiro Semba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuichiro Semba. The network helps show where Yuichiro Semba may publish in the future.

Co-authorship network of co-authors of Yuichiro Semba

This figure shows the co-authorship network connecting the top 25 collaborators of Yuichiro Semba. A scholar is included among the top collaborators of Yuichiro Semba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuichiro Semba. Yuichiro Semba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 0
4 5
5 0
6 0
7 40
8 3
9 12
10 2
11 13
12 0
13 13
14 11
15 2
16 2
17 18
18 24
19 28
20 12

About Yuichiro Semba

Yuichiro Semba is a scholar working on Hematology, Genetics and Oncology, having authored 35 papers that have together received 305 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (8 papers), CRISPR and Genetic Engineering (7 papers) and Chronic Myeloid Leukemia Treatments (5 papers). The work is most often cited by research in Hematology (60 citations), Genetics (33 citations) and Molecular Biology (203 citations). Yuichiro Semba has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Koichi Akashi, Yasuyuki Ohkawa, Jumpei Nogami, Kazumitsu Maehara, Akihito Harada, Takahiro Maeda, Yuya Kunisaki, Chikara Meno, Toshihiro Miyamoto and Shinya Oki. Their work appears in journals such as Nature, Nucleic Acids Research and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026